WashU Medicine News company blog

FDA clears blood test to aid evaluation for Alzheimer's disease

The blood-based biomarker test is based on technology developed at WashU Medicine by Randall Bateman, MD, and David Holtzman, MD.
Points
190
HN comments
106
Submissions
1
Cited by
0 commenters

Science & SpaceTech Industry & Business2026

On Hacker News

SubmittedTitle on HNPointsComments
Aug 24, 2026FDA clears blood test to aid evaluation for Alzheimer's disease by dabinat190106

More from WashU Medicine News

All 3 posts →

Related posts from the same era